Cargando…
Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection
Millions of men each year are faced with a clinical suspicion of prostate cancer (PCa) but the prostate biopsy fails to detect the disease. For the urologists, how to select the appropriate candidate for repeat biopsy is a significant clinical dilemma. Traditional risk-stratification tools in this s...
Autores principales: | Sorokin, Igor, Mian, Badar M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814963/ https://www.ncbi.nlm.nih.gov/pubmed/26112489 http://dx.doi.org/10.4103/1008-682X.156859 |
Ejemplares similares
-
Current and emerging trends in prostate cancer immunotherapy
por: Schatz, Adam, et al.
Publicado: (2019) -
Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer
por: Le, Jesse D, et al.
Publicado: (2014) -
The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014) -
Risk-prediction tools in prostate cancer: the challenge of tailoring
por: Morlacco, Alessandro, et al.
Publicado: (2016) -
Nerve biopsy: Current indications and decision tools
por: Nathani, Dev, et al.
Publicado: (2021)